Represent Labcorp's reproductive genetics, women's health, rare disease, oncology diagnostics, hereditary cancer, molecular diagnostics, genomic profiling, liquid biopsy, ctDNA, MRD, biomarker, NGS-based testing, pathology, hematopathology, cytogenetics, and virtual pathology solutions. Drive new business acquisition, competitive displacement, market penetration, and revenue growth across oncology practices, pathology groups, cancer centers, health systems, integrated delivery networks (IDNs), and academic medical centers.